略過巡覽連結
全部類別
照片
影音新聞
政府機關
國內公司行號
國外公司行號
非營利組織
中文稿
英文稿
有附件
無附件
受理採訪通知

會員登入

歡迎公司行號投遞新聞訊息(如文字、照片或活動預告等),詳洽業務行銷中心:
電話:886-2-2505-1180 轉780~786 或 790~797 傳真:886-2-2502-3805

NoTime標題
27 2017-02-24 19:04:03 REVLIMID® (Lenalidomide) Approved by the European Commission as Monotherapy for the Maintenance Treatment of Patients with Newly Diagnosed Multiple Myeloma after Autologous Stem Cell Transplantation
26 2017-02-24 15:22:31 SES Board of Directors appoints three new members to its Executive Committee
25 2017-02-23 00:00:00 Chunghwa Telecom Launches Exclusive Pioneering LWA 4G+Wi-Fi Services
24 2017-02-21 16:16:28 SES Partners with Globecast to Expand TRT World Reach
23 2017-02-21 09:50:06 AFFIN Bank Implements Moody’s Analytics Software Solutions to Enhance Risk Management Capabilities
22 2017-02-21 09:49:49 Expo 2020 Dubai Partners with SAP to Create ‘Made-For-You’ Experience for Millions of Visitors
21 2017-02-21 09:29:27 SES to Participate in 5G Press and Analyst Event at the Mobile World Congress
20 2017-02-21 09:29:00 Nike Unveils Collection to Celebrate Air Max Day, Highlighted by Release of Nike Air VaporMax
19 2017-02-17 09:29:06 Takeda Completes Acquisition of ARIAD Pharmaceuticals, Inc.
18 2017-02-16 18:28:43 ABB Wins $70 Million in Equipment Orders to Expand European Rail Fleets
17 2017-02-16 09:49:00 TAS Students, IEYI Gold Medal Winners, to Represent Taiwan in World Competition in Japan
16 2017-02-16 09:38:57 BOARD International Achieves Best Results in Its History
15 2017-02-16 09:38:32 Boehringer Ingelheim and Weill Cornell Medicine announce new collaboration to discover next generation COPD treatments
14 2017-02-16 09:25:13 SES and Gilat Join Forces to Make Connectivity at Sea More Accessible
13 2017-02-13 16:58:55 Ferring and Foresee Pharmaceuticals Enter into Exclusive Development and Option Agreement
12 2017-02-13 16:18:24 SES: Number of HD+ Subscribers in Germany Passes Two Million Mark
11 2017-02-10 09:25:35 Afatinib to be evaluated in combination with PD-1 inhibitor pembrolizumab in new trial for patients with squamous cell carcinoma of the lung
10 2017-02-08 14:07:58 ABB delivers growth in fourth quarter
9 2017-02-07 09:43:44 Argo Group Closes Ariel Re Acquisition
8 2017-02-06 14:51:03 SES Supports Luxembourg's Maritime Sector at Euromaritime
7 2017-02-06 09:28:25 Qualcomm and TDK Announce Launch of Joint Venture
6 2017-02-03 15:03:23 SES: Israel Premier Football League Chooses MX1 360 Platform to Speed Up Sports Highlights Production and Distribution
5 2017-02-03 15:03:07 SES and Satcom Global sign an agreement for global Ku-band network
4 2017-02-03 15:03:00 SES Continues to Lead HDTV Development
3 2017-02-03 15:02:44 Ferring Pharmaceuticals and Enteris BioPharma Enter License Agreement to Develop an Oral Formulation of a Peptide-based Injectable Therapeutic
2 2017-02-03 14:59:00 Jardiance® (empagliflozin) becomes first type 2 diabetes medicine in the EU to include cardiovascular death reduction data in label
1 2017-02-03 14:58:00 Murex Named Market Risk Technology Vendor of the Year

Top 中央社訊息平台首頁
新聞稿刊載服務請洽本社業務行銷中心人員,電話(02)2505-1180 轉 780 ~ 786 或 790 ~ 797 本平台資料均由投稿單位輸入後對外公布,資料如有錯誤、遺漏或虛偽不實,均由投稿單位負責
關閉提示
訊息提示
顯示提示